Cost-related Medication Nonadherence among Medicare Beneficiaries with
Cardiovascular Disease Risk Factors: The Role of Comprehension of the
Medicare Program and its Prescription Drug Benefits
Abstract
RATIONALE, AIMS, AND OBJECTIVES: This study aims to investigate how
reported comprehension of the Medicare program and its prescription drug
benefits affects cost-related medication nonadherence (CRN) among
Medicare beneficiaries with cardiovascular disease (CVD) risk factors.
METHODS: This cross-sectional study used the 2017 Medicare Current
Beneficiary Survey Public Use File data and included Medicare
beneficiaries aged ≥ 65 years who reported having at least one CVD risk
factor (i.e., hypertension, hyperlipidemia, diabetes, smoking, and
obesity) (n=2,821). A survey-weighted logistic model was used to examine
associations between lack of difficulty understanding the Medicare
program and its prescription drug benefits and CRN, controlling for
beneficiaries’ demographic (e.g., age) and clinical characteristics
(e.g, comorbidities). This study further analyzed five subgroups based
on the type of CVD risk factors involved. RESULTS: Among Medicare
beneficiaries with CVD risk factors, 14.4% reported CRN. Medicare
beneficiaries with CVD risk factors who reported difficulty
understanding the overall Medicare program and its prescription drug
benefits were more likely to report CRN, compared to those who reported
easy understanding of the overall Medicare program (OR=1.49; 95%
CI=1.09, 2.04; p<0.001) and its prescription drug benefits
(OR=2.01; 95% CI=1.51, 2.67; p<0.001). Similar results were
obtained for the subgroups with obesity, hypertension, or
hyperlipidemia. CONCLUSIONS: Perceived lack of difficulty understanding
the Medicare Program and its prescription drug benefits has a positive
impact on CRN reduction among Medicare beneficiaries with CVD risk
factors, especially those with obesity, hypertension or hyperlipidemia.
Monitoring and enhancing Medicare beneficiaries’ overall understanding
of the Medicare program may reduce CRN.